A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.

INAB READ THE FULL INAB RESEARCH REPORT IN8bio, Inc (NASDAQ:INAB) updates survival data for its INB-100 trial in a February ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Melissa Beiner, M.D., SCA Clinical Development Lead at Biohaven, commented, Our NDA filing is the culmination of over 8 years of clinical research a ...

These protocols generate cells with characteristics associated with specific and desired developmental lineages. Cells derived from such lineages are transplanted into patients in an effort to ...

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® (iptacopan capsules) as ...

The pCR was 37.3% (95% CI, 33.2-41.6) in the durvalumab arm and 27.5% (95% CI, 23.8-31.6) in the comparator arm.

The data included study characteristics (study design, selection criteria, setting and sample size), funding sources, ethical approval, population (age, gender, time since OVF), intervention and ...

We summarised the characteristics of all included trials using frequency ... In 152 trials (75.7%), patients were randomised to treatment or comparator, including 55 trials with some form of blinding ...

Characteristics of demographics and the disease ... These biases may produce diverse effects in different countries. The lack of a comparator group without RA did not allow comparison in this study ...